Early Study of Brain-Permeable BRAF Inhibitor Shows Positive Results - AJMC.com Managed Markets Network
6/10/2022 12:00:00 AM3 years 8 months ago
by AJMC Staff
by AJMC Staff
Brain metastasis from melanoma is particularly deadly and options are limited due to the difficulty of breaching the brain-blood barrier.
Recent research illustrated the potent and prolonged antitumor activity of a BRAF inhibitor, C1a, that can cross the blood-brain barrier to attack brain metastases from malignant melanoma. Brain met… [+2805 chars]
full article...